Drugmakers Aim at Early Stage Cancer Patients With Immunotherapy

Drugmakers Aim at Early Stage Cancer Patients With Immunotherapy


AstraZeneca Plc , Bristol-Myers Squibb Co. and other drugmakers are switching gears on standard drug development in an effort to quickly test powerful new therapies in earlier stages of cancer.



from Biotech News